Effect of tumor necrosis factor-α blocker (infliximab) on blastocyst development in vitro
暂无分享，去创建一个
[1] W. Dmowski,et al. Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-alpha in women with endometriosis. , 2002, Fertility and sterility.
[2] P. Viganò,et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. , 2002, Fertility and sterility.
[3] A. Agarwal,et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. , 2002, Human reproduction.
[4] F. Deer,et al. Recombinant human TNF binding protein-1 (r-hTBP-1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study. , 2001 .
[5] W. Nothnick. Treating endometriosis as an autoimmune disease. , 2001, Fertility and sterility.
[6] R. Papoian,et al. Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally-induced endometriosis in rats. , 2000, Journal of reproductive immunology.
[7] A. Markham,et al. Infliximab: a review of its use in the management of rheumatoid arthritis. , 2000, Drugs.
[8] N. Terakawa,et al. Tumor Necrosis Factor-α Promotes Proliferation of Endometriotic Stromal Cells by Inducing Interleukin-8 Gene and Protein Expression , 2000 .
[9] M. Mueller,et al. Immunobiology of endometriosis. , 2001, Fertility and sterility.